Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -4974.74% is 208% below its 1-year average of -1615.04%, near the low end of its 1-year range (-4974.74%–0.00%).
105.35% below its 12-month average of -2422.56%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -4845.11%.
OPERATING MARGIN
-4974.74%
OPERATING MARGIN AVG TTM
-2422.56%
OPERATING MARGIN AVG 3Y
N/A
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-105.35%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 782 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Attovia Therapeutics, Inc.
Market Cap
$764.86M
Operating Margin
-4974.74%
TTM Avg
-2422.56%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$764.65M
Operating Margin
9.00%
TTM Avg
7.11%
3Y Avg
-27.53%
5Y Avg
-16.39%
Market Cap
$777.34M
Operating Margin
-98.21%
TTM Avg
-366.21%
3Y Avg
-21871.64%
5Y Avg
-19485.10%
Market Cap
$776.43M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$752.61M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$789.07M
Operating Margin
-29.28%
TTM Avg
-127.46%
3Y Avg
-26333.62%
5Y Avg
-23986.43%
Market Cap
$790.46M
Operating Margin
9.86%
TTM Avg
12.61%
3Y Avg
-6.26%
5Y Avg
-239.99%
Market Cap
$796.62M
Operating Margin
-0.31%
TTM Avg
6.92%
3Y Avg
0.39%
5Y Avg
2.91%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Attovia Therapeutics, Inc. (ATTO) | $764.86M | -4974.74% | -2422.56% | N/A | N/A |
| Mesa Laboratories, Inc. (MLAB)vs › | $764.65M | 9.00% | 7.11% | -27.53% | -16.39% |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $777.34M | -98.21% | -366.21% | -21871.64% | -19485.10% |
| Sana Biotechnology, Inc. (SANA)vs › | $776.43M | 0.00% | 0.00% | 0.00% | 0.00% |
| Design Therapeutics, Inc. (DSGN)vs › | $752.61M | 0.00% | 0.00% | 0.00% | 0.00% |
| Apnimed, Inc. (APMD)vs › | $784.52M | N/A | N/A | N/A | N/A |
| Geron Corporation (GERN)vs › | $789.07M | -29.28% | -127.46% | -26333.62% | -23986.43% |
| Gyre Therapeutics, Inc. (GYRE)vs › | $790.46M | 9.86% | 12.61% | -6.26% | -239.99% |
| AdaptHealth Corp. (AHCO)vs › | $796.62M | -0.31% | 6.92% | 0.39% | 2.91% |
| Candel Therapeutics, Inc. (CADL)vs › | $737.10M | 0.00% | 0.00% | -6934.80% | -9894.67% |
Gross Margin
40.4%
Operating Margin
-4974.7%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -4845.11% |
| 2026-03-31 | 0.00% |
| 2025-03-31 | 0.00% |
